Financial Perspectives, Inc Gsk PLC Transaction History

Financial Perspectives, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Jan 09, 2024	SELL	$16.13 - $44.61 $9,984 - $27,613	-619 Closed	0 $0
Q2 2022 Jan 09, 2024	BUY	$42.05 - $47.77 $168 - $191	4 Added 0.65%	619 $26.9 Million
Q1 2022 Jan 09, 2024	BUY	$40.23 - $47.74 $120 - $143	3 Added 0.49%	615 $26.8 Million
Q4 2021 Jan 09, 2024	BUY	$38.88 - $45.31 $116 - $135	3 Added 0.49%	612 $27 Million
Q3 2021 Jan 09, 2024	SELL	$38.79 - $43.16 $240,381 - $267,462	-6,197 Reduced 91.05%	609 $23.3 Million
Q2 2021 Jan 09, 2024	SELL	$36.52 - $41.46 $8.62 Million - $9.78 Million	-235,947 Reduced 97.2%	6,806 $271 Million
Q1 2021 Jan 09, 2024	BUY	$34.27 - $40.01 $8.09 Million - $9.44 Million	235,954 Added 3470.42%	242,753 $6.8 Million
Q4 2020 Jan 09, 2024	SELL	$34.07 - $39.94 $68,003 - $79,720	-1,996 Reduced 22.69%	6,799 $250 Million
Q3 2020 Jan 09, 2024	BUY	$38.11 - $42.99 $76 - $85	2 Added 0.02%	8,795 $331 Million
Q2 2020 Jan 09, 2024	BUY	$37.87 - $43.58 $151 - $174	4 Added 0.05%	8,793 $359 Million
Q1 2020 Jan 09, 2024	BUY	$32.47 - $48.83 $64 - $97	2 Added 0.02%	8,789 $333 Million
Q4 2019 Jan 09, 2024	BUY	$42.0 - $48.25 $369,054 - $423,972	8,787 New	8,787 $413 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Perspectives, Inc with notifications on news.